SHEILA BROWN: Open Payments
NPI 1346863537 · MONROE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 12 payments from 10 companies in 2025. Trend: 2023 $17 · 2024 $70 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Apellis Pharmaceuticals, Inc. | 1 | $24 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: INTELLIS ADAPTIVESTIM, JARDIANCE, Empaveli, REXULTI, QUTENZA, Wegovy, VRAYLAR, BREZTRI.
Industry payments across NC — which companies pay providers there.
